Bayesian Capital Management’s Cabot Corp CBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-3,400
Closed -$283K 580
2025
Q1
$283K Buy
+3,400
New +$293K 0.05% 405
2022
Q4
Sell
-5,240
Closed -$335K 808
2022
Q3
$335K Buy
+5,240
New +$369K 0.07% 380
2018
Q3
Sell
-3,573
Closed -$221K 641
2018
Q2
$221K Sell
3,573
-3,400
-49% -$201K 0.05% 493
2018
Q1
$389K Sell
6,973
-800
-10% -$50.5K 0.1% 330
2017
Q4
$479K Buy
+7,773
New +$467K 0.1% 326
2017
Q2
Sell
-5,233
Closed -$314K 443
2017
Q1
$314K Buy
+5,233
New +$298K 0.15% 248

Other funds holding CBT

Bayesian Capital Management's CBT Position: Q2 2025 in Review

Bayesian Capital Management sold out of Cabot Corp (CBT) in Q2 2025, closing a stake of 3,400 shares — an estimated $283K sold.

Bayesian Capital Management first reported a position in CBT in Q1 2017 and held it in 6 quarters. The position peaked at $479K in Q4 2017. 379 funds tracked by Wall St. Rank hold CBT as of Q2 2025.

  • Bayesian Capital Management reported no remaining Cabot Corp position as of Q2 2025 after selling out during the quarter.
  • Bayesian Capital Management sold 3,400 Cabot Corp shares in Q2 2025, an estimated $283K.
  • Bayesian Capital Management first reported a position in Cabot Corp in Q1 2017 and held it in 6 quarters.
  • Bayesian Capital Management's Cabot Corp position peaked at $479K in Q4 2017.
  • 379 funds tracked by Wall St. Rank held Cabot Corp as of Q2 2025.

Based on Bayesian Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.